Evidence map›Paper›PMID 22764240›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Dynorphins regulate fear memory: from mice to men.

Andras Bilkei-Gorzo, Susanne Erk, Britta Schürmann, Daniela Mauer, Kerstin Michel, Henning Boecker, Lukas Scheef, Henrik Walter, Andreas Zimmer

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Sex differences in fear extinction.Neuroscience and biobehavioral reviews · 2019
    Review
  12. Article
  13. Article
  14. Genetic influences on the neural and physiological bases of acute threat: A research domain criteria (RDoC) perspective.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2016
    Review
  15. Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.Progress in neuro-psychopharmacology & biological psychiatry · 2015
    Review
  16. ASICs and neuropeptides.Neuropharmacology · 2015
    Review
  17. Review
  18. Review
  19. Review
  20. The hypocretin/orexin system mediates the extinction of fear memories.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Andras Bilkei-GorzoInstitute of Molecular Psychiatry, University of Bonn, 53125 Bonn, Germany.
Susanne Erk
Britta Schürmann
Daniela Mauer
Kerstin Michel
Henning Boecker
Lukas Scheef
Henrik Walter
Andreas Zimmer
Institute of Molecular Medicine · INUniversity of Bonn · DE

Funding

VULNERABILITY TO NICOTINE ADDICTIONR01DA016768 · NIDA · POMPEU FABRA UNIVERSITY · PI MALDONADO, RAFAEL · 2004 to 2008
$1.5M
NIDA NIH HHS R01 DA016768
6 · The paper itself

Abstract

Reexposure to trauma reminders is an integral element of trauma-focused cognitive behavioral therapy (Roberts et al., 2009), but little is known about the physiological processes underlying the therapeutic progress. While it is well established that amygdala, prefrontal cortex and hippocampus are key brain structures in fear memory processing (McGaugh, 2004; Herry et al., 2008; Likhtik et al., 2008), it is not well known which neurotransmitters or neuromodulators are involved. Here with a translational approach we investigated the role of dynorphins in the formation and extinction of fear memories in mice and in humans. Mice lacking dynorphin showed an enhanced cue-dependent fear conditioning, as well as delayed extinction in contextual conditioning/extinction paradigms. The pharmacological blockade of κ-opioid receptors before the extinction trials but not before or after the conditioning produced a similar effect. Analysis of neuronal activity, using the immediate early gene c-fos, demonstrated a reduced neuronal activity in key limbic structures during extinction in the absence of dynorphin. Translating these findings into the human domain, fear conditioning and extinction, coupled with functional MRI was then performed in volunteers preselected for a functionally relevant polymorphism in the dynorphin gene. Human volunteers bearing the (T) allele of PDYN (prodynorphin) at rs1997794 showed reduced fear extinction and a significantly diminished functional connectivity between amygdala and ventromedial prefrontal cortex. Our findings establish a role of dynorphin κ-opioid receptor signaling in fear extinction.

Indexed as

AdultAnimalsAnxiety DisordersDynorphinsExtinction, PsychologicalFearFemaleHumansLimbic SystemMaleMemoryMiceMice, KnockoutProto-Oncogene Proteins c-fosReceptors, Opioid, kappaYoung AdultDynorphinsOPRK1 protein, humanProto-Oncogene Proteins c-fosReceptors, Opioid, kappa

Identifiers

PMID22764240
PMCPMC6622224
OpenAlexW2084003388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.